KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Dividends Paid - Common: 2009-2025

Historic Dividends Paid - Common for Colgate Palmolive (CL) over the last 17 years, with Sep 2025 value amounting to $420.0 million.

  • Colgate Palmolive's Dividends Paid - Common rose 2.94% to $420.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year increase of 1.85%. This contributed to the annual value of $1.8 billion for FY2024, which is 2.29% up from last year.
  • Colgate Palmolive's Dividends Paid - Common amounted to $420.0 million in Q3 2025, which was down 11.39% from $474.0 million recorded in Q2 2025.
  • Colgate Palmolive's Dividends Paid - Common's 5-year high stood at $514.0 million during Q4 2024, with a 5-year trough of $376.0 million in Q1 2021.
  • In the last 3 years, Colgate Palmolive's Dividends Paid - Common had a median value of $420.0 million in 2025 and averaged $439.8 million.
  • Its Dividends Paid - Common has fluctuated over the past 5 years, first dropped by 2.22% in 2022, then increased by 4.82% in 2023.
  • Colgate Palmolive's Dividends Paid - Common (Quarterly) stood at $496.0 million in 2021, then fell by 2.22% to $485.0 million in 2022, then grew by 4.33% to $506.0 million in 2023, then grew by 1.58% to $514.0 million in 2024, then grew by 2.94% to $420.0 million in 2025.
  • Its Dividends Paid - Common stands at $420.0 million for Q3 2025, versus $474.0 million for Q2 2025 and $406.0 million for Q1 2025.